490 studies found for:    amyloid
Show Display Options
Rank Status Study
1 Unknown  F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
Intervention:
2 Completed
Has Results
Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: florbetapir F 18
3 Completed Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
Conditions: Alzheimer Disease;   Amyloid Beta-Protein
Intervention: Drug: Florbetaben (BAY94-9172)
4 Completed
Has Results
Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Conditions: Down Syndrome;   Amyloid Beta-protein
Intervention: Drug: Florbetaben (BAY94-9172)
5 Completed
Has Results
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
Condition: Normal Pressure Hydrocephalus
Intervention: Drug: [18F] Flutemetamol
6 Completed
Has Results
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
Condition: Healthy
Intervention: Drug: [18F] Flutemetamol
7 Enrolling by invitation CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
8 Completed
Has Results
Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir F 18
9 Recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
Intervention:
10 Recruiting Efficacy and Safety of ISIS-TTRRx in Familial Amyloid Polyneuropathy
Condition: Familial Amyloid Polyneuropathy
Interventions: Drug: ISIS TTR Rx;   Drug: Placebo
11 Recruiting Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Condition: Non Traumatic Primary Intracerebral Hemorrhage
Intervention: Other: Pet AV-45 (Florbetapir F 18) Cerebral Amyloid imaging
12 Completed Radioimmunoimaging of Light Chain (AL) Amyloidosis
Condition: AL Amyloidosis
Intervention: Biological: Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)
13 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
14 Active, not recruiting Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Condition: Alzheimer Disease
Intervention: Drug: Florbetaben (BAY94-9172)
15 Recruiting Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
Condition: Cerebral Amyloid Angiopathy
Interventions: Biological: Ponezumab;   Other: placebo
16 Enrolling by invitation Imaging of Brain Amyloid Plaques in the Aging Population
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Frontotemporal Dementia;   Vascular Dementia
Interventions: Drug: Pittsburgh Compound B (C-11 PiB);   Drug: F-18 FDG
17 Completed Efficacy and Safety of Plasma Exchange With 5% Albutein in Beta-Amyloid Peptide Clearance in Cerebrospinal Fluid
Condition: Alzheimer's Disease
Intervention: Biological: Albutein 5%
18 Enrolling by invitation Amyloid Accumulation After Mild Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention: Drug: [18F]AV-45 PET amyloid binding imaging
19 Completed
Has Results
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
Conditions: Familial Amyloid Polyneuropathy;   ATTR-PN
Intervention: Drug: Fx-1006A
20 Not yet recruiting A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
Condition: Alzheimer's Disease
Interventions: Drug: Bexarotene;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years